Trial
NCT07012057
Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborators
—
Condition
Myositis
Intervention
Deucravacitinb
Why stopped
Manufacturer discontinued investigational drug supply.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-24